within Pharmacolibrary.Drugs.ATC.J;

model J05AF07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 0.00021,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.09670000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.001999999999999
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J05AF07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor (NRTI) used as an antiretroviral medication for the treatment and prevention of HIV-1 infection and chronic hepatitis B. It is approved and widely used today as part of combination therapy regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults following single oral dose of tenofovir disoproxil 300 mg.</p><h4>References</h4><ol><li><p>Bierhoff, M, et al., &amp; van Vugt, M (2019). Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review. <i>Antiviral therapy</i> 24(7) 529–540. DOI:<a href=&quot;https://doi.org/10.3851/IMP3341&quot;>10.3851/IMP3341</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31868655/&quot;>https://pubmed.ncbi.nlm.nih.gov/31868655</a></p></li><li><p>Dando, TM, &amp; Wagstaff, AJ (2004). Emtricitabine/tenofovir disoproxil fumarate. <i>Drugs</i> 64(18) 2075–2084. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200464180-00005&quot;>10.2165/00003495-200464180-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15341498/&quot;>https://pubmed.ncbi.nlm.nih.gov/15341498</a></p></li><li><p>Eke, AC, et al., &amp; Capparelli, EV (2021). Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate. <i>Antimicrobial agents and chemotherapy</i> 65(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02168-20&quot;>10.1128/AAC.02168-20</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33318014/&quot;>https://pubmed.ncbi.nlm.nih.gov/33318014</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J05AF07;
